|
关键字
|
AH10121,AMM00085G, Carcinoembryonic Antigen (CEA) / CD66 Antibody - With BSA and Azide,Leading biology,abgent
|
|
产品描述
|
Certainly! Here's a detailed product information outline for the Carcinoembryonic Antigen (CEA) / CD66 Antibody with BSA and Azide:
---
Product Name:
Carcinoembryonic Antigen (CEA) / CD66 Antibody with BSA and Azide
---
Product Description:
This high-quality Carcinoembryonic Antigen (CEA) / CD66 Antibody is designed for specific detection of CEA, a well-known tumor marker. This antibody is formulated with BSA (Bovine Serum Albumin) and Azide to enhance stability and shelf-life. It is ideal for use in various immunoassays to detect the presence of CEA in tissue samples or other biological materials.
---
Key Features:
- High Specificity: Targeted binding to CEA, ensuring minimal cross-reactivity with other proteins.
- Enhanced Stability: Formulated with BSA and Azide to maintain antibody activity over time.
- Versatility: Suitable for multiple applications, including ELISA, Western blotting, immunohistochemistry, and more.
- Quality Assurance: Each batch is rigorously tested to ensure consistent performance.
- Convenient Packaging: Available in various sizes to meet different research needs.
---
Storage:
- Temperature: Store at 2-8°C for short-term use. For long-term storage, aliquot and freeze at -20°C to prevent repeated freeze-thaw cycles.
- Avoid Exposure: Protect from light and avoid exposure to frequent temperature changes to maintain antibody integrity.
- Stability: Stable for up to 1 year when stored as recommended.
---
What's Included:
- CEA / CD66 Antibody: Supplied in a buffer solution with BSA and Azide to ensure optimal performance and stability.
- Detailed Protocols: Comprehensive instructions for use in various applications.
- Certificate of Analysis: Documentation providing batch-specific information, including concentration and purity.
---
Applications:
- Clinical Research: Ideal for studying tumor markers in oncology research.
- Diagnostic Development: Useful in the development of diagnostic assays for detecting cancer.
- Basic Research: Suitable for understanding CEA's role in cell adhesion and signaling pathways.
- Immunoassays: Effective in techniques such as ELISA, Western blotting, and immunohistochemistry for detecting CEA in samples.
- Biomarker Studies: Employed in the investigation of CEA as a biomarker in various cancers.
---
This comprehensive product information aims to provide researchers and clinicians with all necessary details to effectively utilize the CEA / CD66 Antibody in their work, ensuring reliable and reproducible results.
|